APA (7th ed.) Citation

Yokomizo, A., Shiota, M., Morokuma, F., Eto, M., Matsuyama, H., Matsumoto, H., . . . Kishimoto, J. (2024). GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone‐sensitive prostate cancer; KYUCOG‐1401. International Journal of Urology, 31(4), 362. https://doi.org/10.1111/iju.15371

Chicago Style (17th ed.) Citation

Yokomizo, Akira, et al. "GnRH Antagonist Monotherapy Versus a GnRH Agonist Plus Bicalutamide for Advanced Hormone‐sensitive Prostate Cancer; KYUCOG‐1401." International Journal of Urology 31, no. 4 (2024): 362. https://doi.org/10.1111/iju.15371.

MLA (9th ed.) Citation

Yokomizo, Akira, et al. "GnRH Antagonist Monotherapy Versus a GnRH Agonist Plus Bicalutamide for Advanced Hormone‐sensitive Prostate Cancer; KYUCOG‐1401." International Journal of Urology, vol. 31, no. 4, 2024, p. 362, https://doi.org/10.1111/iju.15371.